Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
948,493
-
Share change
-
+18,316
-
Total reported value
-
$8,931,000
-
Price per share
-
$9.41
-
Number of holders
-
22
-
Value change
-
+$741,691
-
Number of buys
-
12
-
Number of sells
-
5
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q1 2015
As of 31 Mar 2015,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
948,493 shares.
The largest 10 holders included
683 Capital Management, LLC, Park West Asset Management LLC, DRILL CRAIG A, PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LP, GOLDMAN SACHS GROUP INC, GRT CAPITAL PARTNERS LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.